Literature DB >> 2439031

Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.

B S Breur-Vriesendorp, A J Dekker-Saeys, P Ivanyi.   

Abstract

HLA-B27 subtypes can be defined by cellular, serological, and biochemical techniques. The seven subtypes so far identified represent structural variants of B27 with limited variations in the amino acid sequence of the B27 molecule. The routinely typed B27 'antigen' remains a common (shared, public) determinant present on various B27 molecules. The distribution of the subtypes varies strongly among different ethnic groups and they occur in different linkage disequilibria. In the healthy Dutch population only two subtypes were found: B27W (B27 X 1, B27M2+) (90%) and B27K (B27 X 2, B27M2-) (10%). A similar distribution of B27 subtypes was observed in 91 unrelated Dutch patients with ankylosing spondylitis (AS)--namely, 92% B27W and 8% B27K. In Oriental populations the subtype distribution is quite different: B27W occurs in less than 50%, whereas more than 50% individuals are of the B27C and B27D subtypes. Preliminary data indicate that the distribution of subtypes in healthy and diseased Oriental individuals is similar. These results suggest that the B27 and disease (AS) association is not correlated with the structural variations of one of the B27 subtypes, but with a common B27 determinant shared by various B27 subtypes. Consequently, the disease is older than the B27 variants. Further studies on disease and subtype distribution in various ethnic groups might contribute to a better understanding of the origin of both.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439031      PMCID: PMC1002140          DOI: 10.1136/ard.46.5.353

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

Authors:  M A Vega; A Ezquerra; S Rojo; P Aparicio; R Bragado; J A López de Castro
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

2.  An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

Authors:  J J Neefjes; B S Breur-Vriesendorp; G A van Seventer; P Iványi; H L Ploegh
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  Tryptic peptide mapping identifies structural heterogeneity among six variants of HLA-B27.

Authors:  S Y Choo; C Seyfreid; J A Hansen; G T Nepom
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Primary structure of papain-solubilized human histocompatibility antigen HLA-B27.

Authors:  A Ezquerra; R Bragado; M A Vega; J L Strominger; J Woody; J A López de Castro
Journal:  Biochemistry       Date:  1985-03-26       Impact factor: 3.162

5.  Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes.

Authors:  A Toubert; E Gomard; F C Grumet; B Amor; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Monoclonal antibody (B27M2) subdividing HLA-B27.

Authors:  F C Grumet; B M Fendly; L Fish; S Foung; E G Engleman
Journal:  Hum Immunol       Date:  1982-08       Impact factor: 2.850

7.  Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients.

Authors:  H L Coppin; H O McDevitt
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

8.  Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes.

Authors:  M A Vega; L Wallace; S Rojo; R Bragado; P Aparicio; J A López de Castro
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Identification of new B27 subtypes (B27C and B27D) prevalent in oriental populations.

Authors:  B S Breur-Vriesendorp; J C Neefjes; B Huis; G A van Seventer; H L Ploegh; P Iványi
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

10.  Gene conversion-like mechanisms may generate polymorphism in human class I genes.

Authors:  G H Seemann; R S Rein; C S Brown; H L Ploegh
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

View more
  29 in total

Review 1.  HLA-B27 subtypes: implications for the spondyloarthropathies.

Authors:  L MacLean
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  HLA-A29 subtypes and birdshot chorioretinopathy.

Authors:  L P de Waal; N M Lardy; A R van der Horst; G S Baarsma; A Kijlstra; L Noens; H A Priem
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

4.  Non-HLA-B27 genetic factors in HLA-B27 associated diseases.

Authors:  T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Status of an unpaired thiol group on the HLA-B27 epitope.

Authors:  L McLean; D Perrett; V R Winrow; J R Archer
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

6.  Serological and biochemical identification of HLA-Aw33 subtypes.

Authors:  L P de Waal; H J Mesman; C P Engelfriet
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  HLA-B27 and the causes of arthritis: does molecular biology help?

Authors:  J R Archer; V R Winrow
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

Review 8.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 9.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

10.  Seronegative spondyloarthropathies and HLA-B27 subtyes: a study in Asian Indians.

Authors:  U Kanga; N K Mehra; C L Larrea; N M Lardy; A Kumar; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.